GRAIL Reports Third Quarter 2025 Financial Results

Q3 U.S. Galleri Revenue Grew 28% Year-Over-Year to $32.6 Million

Q3 Galleri Tests Sold Grew 39% Year-Over-Year to More Than 45,000

Galleri PMA Submission to FDA Now Anticipated in Q126

Read more at prnewswire.com